John Griffin Net Worth

The estimated Net Worth of John M. Griffin is at least $18.3 Million dollars as of 14 November 2022. Mr. Griffin owns over 26,902 units of Hologic stock worth over $15,669,638 and over the last 10 years he sold HOLX stock worth over $0. In addition, he makes $2,623,020 as General Counsel at Hologic.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Mr. Griffin HOLX stock SEC Form 4 insiders trading

John has made over 7 trades of the Hologic stock since 2016, according to the Form 4 filled with the SEC. Most recently he exercised 26,902 units of HOLX stock worth $1,098,947 on 14 November 2022.

The largest trade he's ever made was exercising 26,902 units of Hologic stock on 14 November 2022 worth over $1,098,947. On average, John trades about 3,115 units every 65 days since 2015. As of 14 November 2022 he still owns at least 195,846 units of Hologic stock.

You can see the complete history of Mr. Griffin stock trades at the bottom of the page.

John Griffin biography

John M. Griffin serves as General Counsel of the Company. Mr. Griffin joined us in February 2015 as General Counsel with nearly 30 years of experience across a broad spectrum of legal matters. Mr. Griffin worked at Covidien from 2000 to 2015 where he most recently served as Vice President, Deputy General Counsel. Previously, from 1994 to 2000, Mr. Griffin served as Assistant United States Attorney in Boston, Massachusetts, and prosecuted complex criminal cases. He began his career at Nutter, McClennen & Fish in Boston. Mr. Griffin currently serves on the board of directors for Por Cristo in Boston and New England Legal Foundation. He also serves as Treasurer and on the Board of Directors for Health Care Volunteers International. He has a Juris Doctor degree from Harvard Law School and a Bachelor of Arts in political science from Columbia University.

What is the salary of John Griffin?

As the General Counsel of Hologic, the total compensation of John Griffin at Hologic is $2,623,020. There are 3 executives at Hologic getting paid more, with Stephen MacMillan having the highest compensation of $12,374,800.

How old is John Griffin?

John Griffin is 59, he's been the General Counsel of Hologic since 2015. There are 5 older and 13 younger executives at Hologic. The oldest executive at Hologic, Inc. is Dr. Jay A. Stein, 78, who is the Co-Founder, Chairman Emeritus, CTO & Sr. VP.

What's John Griffin's mailing address?

John's mailing address filed with the SEC is Campus Drive, Marlborough, Middlesex County, Massachusetts, 01752, United States.

Insiders trading at Hologic

Over the last 30 years, insiders at Hologic have traded over $311,276,394 worth of Hologic stock and bought 385,967 units worth $8,452,795 . The most active insiders traders include Carl Chigh River Limited Pa..., Carl C Icahn, and Stephen P Macmillan. On average, Hologic executives and independent directors trade stock every 22 days with the average trade being worth of $3,042,940. The most recent stock trade was executed by Karleen Marie Oberton on 29 August 2024, trading 52,679 units of HOLX stock currently worth $4,243,820.

What does Hologic do?

driven by our ethos, the science of sure, we’re a diverse, dedicated, creative team that develops, markets and services some of the most innovative and accurate diagnostic imaging systems and surgical products on the planet. while we’re focused and passionate about our work, we never forget that what we’re really doing is giving people greater confidence and peace of mind in their diagnosis—enabling healthier lives, everywhere, every day. connect with us at hologic.com, on facebook at facebook.com/hologicjobs, and on twitter @hologic_jobs.

Complete history of Mr. Griffin stock trades at Hologic

Hologic executives and stock owners

Hologic executives and other stock owners filed with the SEC include:

• Stephen MacMillan,
  Chairman of the Board, President, Chief Executive Officer
• Stephen P. MacMillan,
  Chairman, CEO & Pres
• Kevin Thornal,
  Division President, Diagnostics
• John Griffin,
  General Counsel
• Peter Valenti,
  Division President - Breast and Skeletal Health
• Karleen Oberton,
  Chief Financial Officer
• Kevin R. Thornal,
  Division Pres of Diagnostic Solutions
• John M. Griffin,
  Gen. Counsel
• Sean S. Daugherty,
  Group Pres of Breast/Skeletal Health & GYN Surgical Solutions
• Sally Crawford,
  Lead Independent Director
• Ludwig Hantson,
  Independent Director
• Charles Dockendorff,
  Independent Director
• Scott Garrett,
  Independent Director
• Namal Nawana,
  Independent Director
• Amy Wendell,
  Independent Director
• Christiana Stamoulis,
  Independent Director
• Michael Watts,
  Vice President - Investor Relations and Corporate Communications
• Allison Bebo,
  Senior Vice President - Human Resources
• Mike Kelly,
  Chief Supply Chain Officer and Corp. VP of Quality Assurance & Regulatory Affairs
• Paul Malenchini,
  Chief Information Officer
• Elisabeth A. Hellmann,
  Sr. VP of Global HR & Corp. Communications
• Ryan Simon,
  VP of Investor Relations
• Monica Aguirre Berthelot,
  Chief of Staff
• Sanjay Prabhakaran,
  Regional Pres of Asia Pacific
• Jan Verstreken,
  Group Pres of International
• Dr. Jay A. Stein,
  Co-Founder, Chairman Emeritus, CTO & Sr. VP
• Elaine Ullian,
  Director
• Nancy Leaming,
  Director
• Thomas A. West,
  Div President & GM, Diagnostic
• Christopher J Coughlin,
  Director
• Eric B. Compton,
  COO
• Robert W. Mc Mahon,
  Chief Financial Officer
• Lawrence M Levy,
  Director
• Carl Hull,
  SVP and GM of Diagnostics
• Peter Soltani,
  Vice President
• Benjamin Jordan Cohn,
  Principal Accounting Officer
• Steven S. Williamson,
  SVP, GYN Surgical
• John R Pekarsky,
  Sr. VP, Sales
• Howard Jr Doran,
  Vice President & BUD, ThinPrep
• Arthur G Lerner,
  Director
• Laurie Fajardo,
  Director
• Robert Cascella,
  President & COO
• William A Peck,
  Director
• Stuart A Kingsley,
  President, Surgical Division
• Irwin Jacobs,
  Director
• C William Mcdaniel,
  Director
• Stetten Eric Von,
  Vice President
• Daniel J Levangie,
  Director
• Patrick J Sullivan,
  Director
• Wayne Wilson,
  Director
• Jay A Stein,
  Director
• Samuel J. Merksamer,
  Director
• Jonathan Christodoro,
  Director
• David R Jr Lavance,
  Director
• Claus Egstrand,
  SVP and GM, International
• Carl Chigh River Limited Pa...,
  
• Rohan Hastie,
  Group VP & GM, Diagnostics
• Roger D. Mills,
  SVP & GM, Service & Operations
• Robert H Lavallee,
  Vice President
• Mark J Casey,
  Senior V.P & General Counsel
• Carl C Icahn,
  10% owner
• David Harding,
  SVP, International
• David J Brady,
  SVP, Human Resources
• Glenn P Muir,
  Executive VP & CFO
• John W Cumming,
  Chairman & CEO
• Sean S. Daugherty,
  Group President, BSH & Surg.
• Jan Verstreken,
  Group President, International
• Nanaz Mohtashami,
  Director
• Brandon Schnittker,
  Div. President, GYN Surgical
• Elisabeth A Hellmann,
  SVP, Human Resources
• Erik S Anderson,
  Div. Pres., Breast & Skeletal
• Essex D Mitchell,
  Div. President, GYN Surgical
• Stacey D. Stewart,
  Director
• Jennifer M Schneiders,
  President, Diag. Solutions
• Peter Paul Dunne,
  SVP, Human Resources